nodes	percent_of_prediction	percent_of_DWPC	metapath
Icatibant—BDKRB2—penis—Crohn's disease	0.193	0.333	CbGeAlD
Icatibant—ANPEP—bile—Crohn's disease	0.147	0.254	CbGeAlD
Icatibant—ANPEP—Glutathione metabolism—GPX4—Crohn's disease	0.0459	0.109	CbGpPWpGaD
Icatibant—ANPEP—gall bladder—Crohn's disease	0.0408	0.0705	CbGeAlD
Icatibant—BDKRB2—smooth muscle tissue—Crohn's disease	0.0326	0.0564	CbGeAlD
Icatibant—BDKRB2—mammalian vulva—Crohn's disease	0.0294	0.0508	CbGeAlD
Icatibant—ANPEP—epithelium—Crohn's disease	0.0211	0.0365	CbGeAlD
Icatibant—ANPEP—smooth muscle tissue—Crohn's disease	0.0203	0.0352	CbGeAlD
Icatibant—BDKRB2—Peptide GPCRs—CCR9—Crohn's disease	0.0201	0.0478	CbGpPWpGaD
Icatibant—ANPEP—skin of body—Crohn's disease	0.0201	0.0347	CbGeAlD
Icatibant—ANPEP—mammalian vulva—Crohn's disease	0.0183	0.0316	CbGeAlD
Icatibant—ANPEP—lymphoid tissue—Crohn's disease	0.0163	0.0281	CbGeAlD
Icatibant—ANPEP—digestive system—Crohn's disease	0.0161	0.0278	CbGeAlD
Icatibant—BDKRB2—lymph node—Crohn's disease	0.0147	0.0254	CbGeAlD
Icatibant—BDKRB2—Peptide ligand-binding receptors—ACKR2—Crohn's disease	0.0144	0.0342	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (q) signalling events—MLN—Crohn's disease	0.0138	0.0328	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—MLN—Crohn's disease	0.0137	0.0324	CbGpPWpGaD
Icatibant—BDKRB2—Direct p53 effectors—PRDM1—Crohn's disease	0.0136	0.0322	CbGpPWpGaD
Icatibant—BDKRB2—Peptide GPCRs—CCR6—Crohn's disease	0.0133	0.0316	CbGpPWpGaD
Icatibant—ANPEP—C-MYB transcription factor network—MPO—Crohn's disease	0.0124	0.0294	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—MLN—Crohn's disease	0.0124	0.0294	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	0.0113	0.0268	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.00966	0.0229	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—CCR9—Crohn's disease	0.00946	0.0225	CbGpPWpGaD
Icatibant—ANPEP—C-MYB transcription factor network—TAB1—Crohn's disease	0.00934	0.0222	CbGpPWpGaD
Icatibant—ANPEP—lymph node—Crohn's disease	0.00918	0.0159	CbGeAlD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.00916	0.0217	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (q) signalling events—GPR65—Crohn's disease	0.00891	0.0212	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—CCR9—Crohn's disease	0.00798	0.019	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—GPR65—Crohn's disease	0.00797	0.0189	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.00741	0.0176	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—ACKR2—Crohn's disease	0.00736	0.0175	CbGpPWpGaD
Icatibant—BDKRB2—Direct p53 effectors—HSPA1B—Crohn's disease	0.00724	0.0172	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—SBSPON—Crohn's disease	0.00708	0.0168	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—MLN—Crohn's disease	0.00697	0.0166	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.00689	0.0163	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.00635	0.0151	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—CCR6—Crohn's disease	0.00627	0.0149	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.0059	0.014	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—CCR6—Crohn's disease	0.00529	0.0126	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.00491	0.0117	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CCR9—Crohn's disease	0.00483	0.0115	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (q) signalling events—RASGRP1—Crohn's disease	0.0046	0.0109	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—GPR65—Crohn's disease	0.00449	0.0107	CbGpPWpGaD
Icatibant—ANPEP—C-MYB transcription factor network—CD4—Crohn's disease	0.00441	0.0105	CbGpPWpGaD
Icatibant—ANPEP—C-MYB transcription factor network—PTGS2—Crohn's disease	0.00438	0.0104	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.00432	0.0103	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.0042	0.00998	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—Crohn's disease	0.00412	0.00978	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—MLN—Crohn's disease	0.00394	0.00935	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—ACKR2—Crohn's disease	0.00377	0.00896	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.0037	0.00879	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—MLN—Crohn's disease	0.00358	0.0085	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CCR6—Crohn's disease	0.0032	0.0076	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—PTGER4—Crohn's disease	0.00282	0.00669	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CCR9—Crohn's disease	0.00273	0.00648	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—GPR65—Crohn's disease	0.00254	0.00603	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CCR9—Crohn's disease	0.00248	0.00589	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—GPR65—Crohn's disease	0.00231	0.00547	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—ACKR2—Crohn's disease	0.00223	0.00529	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—MLN—Crohn's disease	0.00211	0.00502	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	0.0021	0.00499	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—CXCL8—Crohn's disease	0.00202	0.0048	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	0.002	0.00476	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—TAGAP—Crohn's disease	0.00193	0.00459	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CCR6—Crohn's disease	0.00181	0.0043	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—CXCL8—Crohn's disease	0.0017	0.00405	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—RSPO3—Crohn's disease	0.00169	0.00401	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CCR6—Crohn's disease	0.00164	0.0039	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—SEL1L—Crohn's disease	0.0016	0.0038	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—PTGER4—Crohn's disease	0.00159	0.00378	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CCR9—Crohn's disease	0.00147	0.00348	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—PTGER4—Crohn's disease	0.00145	0.00343	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—GPR65—Crohn's disease	0.00136	0.00323	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—IL3—Crohn's disease	0.00136	0.00322	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.00135	0.00322	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—RASGRP1—Crohn's disease	0.00131	0.00312	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—IL3—Crohn's disease	0.00123	0.00293	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—RASGRP1—Crohn's disease	0.00119	0.00283	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CXCL8—Crohn's disease	0.00103	0.00245	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	0.00103	0.00244	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CCR6—Crohn's disease	0.000971	0.0023	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—IL2RA—Crohn's disease	0.00095	0.00226	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—RBX1—Crohn's disease	0.000878	0.00208	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—IL2RA—Crohn's disease	0.000863	0.00205	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PTGER4—Crohn's disease	0.000855	0.00203	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—CXCL8—Crohn's disease	0.000794	0.00188	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—UBE2D1—Crohn's disease	0.00077	0.00183	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—RIPK2—Crohn's disease	0.000746	0.00177	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—IL3—Crohn's disease	0.000728	0.00173	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—RASGRP1—Crohn's disease	0.000704	0.00167	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—JAK2—Crohn's disease	0.000639	0.00152	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—SOCS1—Crohn's disease	0.000638	0.00151	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—TYK2—Crohn's disease	0.000608	0.00144	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CXCL8—Crohn's disease	0.000583	0.00138	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—JAK2—Crohn's disease	0.00058	0.00138	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—SMAD3—Crohn's disease	0.000551	0.00131	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CXCL8—Crohn's disease	0.000529	0.00126	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—IL2RA—Crohn's disease	0.00051	0.00121	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—TYK2—Crohn's disease	0.000359	0.000853	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—JAK2—Crohn's disease	0.000343	0.000814	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CXCL8—Crohn's disease	0.000313	0.000743	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—IL6—Crohn's disease	0.000297	0.000706	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—STAT3—Crohn's disease	0.000252	0.000597	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—IL6—Crohn's disease	0.000176	0.000417	CbGpPWpGaD
